Abdullah Pandor

All publications

Journal articles

• Davis S, Goodacre S, Horner D, Pandor A, Holland M, de Wit K, Hunt BJ & Griffin XL (2024) Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling study. BMJ Medicine, 3(1), e000408-e000408.
• Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Hunt BJ, Daru J & Goodacre S (2024) Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysis. Journal of Thrombosis and Haemostasis.
• Hunt B, Sampson F, Goodacre S, Pandor A, Nelson-Piercy C, Daru J, Carser R, Metry A & Davis S (2023) PB1532 How Can We Improve Recruitment to Trials for Prevention of Venous Thromboembolism during Pregnancy and the Puerperium? A Qualitative Evaluation of the Patients' Perspective. Research and Practice in Thrombosis and Haemostasis, 7, 101939-101939.
• Pandor A (2023) Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis. Health Technology Assessment, 27(14).
• Davis S, Goodacre S, Horner D, Pandor A, Griffin XL, de Wit K, Hunt BJ & Holland M (2023) Decision-analysis modelling of effectiveness and cost-effectiveness of pharmacological thromboprophylaxis for surgical inpatients, using variable risk assessment models or other strategies. Journal of Thrombosis and Haemostasis.
• Pandor A, Fuller G, Essat M, Sabir L, Holt C, Buckley Woods H & Chatha H (2022) Individual risk factors predictive of major trauma in pre-hospital injured older patients : a systematic review. British Paramedic Journal, 6(4), 26-40.
• Pandor A, Tonkins M, Goodacre S, Sworn K, Clowes M, Griffin XL, Holland M, Hunt BJ, de Wit K & Horner D (2021) Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review. BMJ Open, 11(7), e045672-e045672.
• Fuller G, Pandor A, Essat M, Sabir L, Buckley-Woods H, Chatha H, Holt C, Keating S & Turner J (2021) Diagnostic accuracy of prehospital triage tools for identifying major trauma in elderly injured patients: A systematic review. Journal of Trauma and Acute Care Surgery, 90(2), 403-412. View this article in WRRO
• Bessey A, Chilcott J, Pandor A & Paisley S (2020) The cost-effectiveness of expanding the UK newborn bloodspot screening programme to include five additional inborn errors of metabolism. International Journal of Neonatal Screening, 6(4). View this article in WRRO
• Horner D, Stevens JW, Pandor A, Nokes T, Keenan J, Wit K & Goodacre S (2020) Reply to Thromboprophylaxis in temporary lower limb immobilization : extrapolate with care. Journal of Thrombosis and Haemostasis, 18(2), 519-520. View this article in WRRO
• Horner D, Stevens JW, Pandor A, Nokes T, Keenan J, de Wit K & Goodacre S (2020) Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury : systematic review and network meta‐analysis. Journal of Thrombosis and Haemostasis, 18(2), 422-438. View this article in WRRO
• Pandor A, Horner D, Davis S, Goodacre S, Stevens JW, Clowes M, Hunt BJ, Nokes T, Keenan J & de Wit K (2019) Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation. Health Technology Assessment, 23(63), 1-190. View this article in WRRO
• Horner D, Goodacre S, Pandor A, Nokes T, Keenan J, Hunt B, Davis S, Stevens JW & Hogg K (2019) Thromboprophylaxis in lower limb immobilisation after injury (TiLLI). Emergency Medicine Journal, 0, 1-6. View this article in WRRO
• Davis S, Goodacre S, Pandor A, Horner D, Stevens JW, Wit K & Hunt BJ (2019) Decision‐analysis modelling of the effects of thromboprophylaxis for people with lower limb immobilisation for injury. British Journal of Haematology, 186(1), 166-168. View this article in WRRO
• Pandor A, Kaltenthaler E, Martyn-St James M, Wong R, Cooper K, Dimairo M, O’Cathain A, Campbell F & Booth A (2019) Delphi consensus reached to produce a decision tool for SelecTing Approaches forRapid Reviews (STARR). Journal of Clinical Epidemiology. View this article in WRRO
• Horner D, Pandor A, Goodacre S, Clowes M & Hunt BJ (2018) Individual risk factors predictive of venous thromboembolism in patients with temporary lower limb immobilisation due to injury: a systematic review.. Journal of Thrombosis and Haemostasis. View this article in WRRO
• Archer R, Hock E, Hamilton J, Stevens J, Essat M, Poku E, Clowes M, Pandor A & Stevenson M (2018) Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.. Health Technology Assessment, 22(66), 1-294. View this article in WRRO
• Dickson R, Boland A, Duarte R, Kotas E, Woolacott N, Hodgson R, Riemsma R, Grimm S, Ramaekers B, Joore M , Büyükkaramikli N et al (2018) EMA and NICE Appraisal Processes for Cancer Drugs: Current Status and Uncertainties. Applied Health Economics and Health Policy. View this article in WRRO
• Rafia R, Pandor A, Davis S, Stevens JW, Harnan S, Clowes M, Sorour Y & Cutting R (2018) Obinutuzumab with Bendamustine for Treating Follicular Lymphoma Refractory to Rituximab: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(10), 1143-1151. View this article in WRRO
• Stevenson M, Pandor A, Hamilton J, Stevens J, Rowntree C, Martyn-St James M, Rawdin A & Wong R (2018) Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(7), 759-768. View this article in WRRO
• Pandor A, Stevenson M, Stevens J, James MM-S, Hamilton J, Byrne J, Rudin C, Rawdin A & Wong R (2018) Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 36(8), 903-915. View this article in WRRO
• Squires H, Pandor A, Thokala P, Stevens JW, Kaltenthaler E, Clowes M, Coleman R & Wyld L (2018) Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.. PharmacoEconomics, 36(1), 29-38. View this article in WRRO
• Scope A, Essat M, Pandor A, Rafia R, Ward S, Wyld L, Cross S & Woods H (2017) Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimens in breast cancer management: a systematic review.. International Journal of Technology Assessment in Health Care, 33(1), 32-45. View this article in WRRO
• Kearns B, Pandor A, Stevenson M, Hamilton J, Chambers D, Clowes M, Graham J & Kumar MS (2016) Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(4), 415-424. View this article in WRRO
• Kaltenthaler E, Cooper K, Pandor A, Martyn-St James M, Chatters R & Wong R (2016) The use of rapid review methods in health technology assessments: 3 case studies. BMC Medical Research Methodology, 16(1). View this article in WRRO
• Stevenson M, Pandor A, Martyn-St James M, Rafia R, Uttley L, Stevens J, Sanderson J, Wong R, Perkins GD, McMullan R & Dark P (2016) Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.. Health Technology Assessment, 20(46), 1-246. View this article in WRRO
• Pandor A, Pollard D, Chico T, Henderson R & Stevenson M (2016) Rivaroxaban for Preventing Atherothrombotic Events in People with Acute Coronary Syndrome and Elevated Cardiac Biomarkers: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 34(5), 463-477. View this article in WRRO
• Pandor A, Kaltenthaler E, Higgins A, Lorimer K, Smith S, Wylie K & Wong R (2015) Sexual health risk reduction interventions for people with severe mental illness: a systematic review. BMC Public Health, 15(1).
• Stevenson M, Pandor A, Stevens JW, Rawdin A, Rice P, Thompson J & Morgan MY (2015) Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 33(8), 833-847. View this article in WRRO
• Goodacre S, Stevens JW, Pandor A, Poku E, Ren S, Cantrell A, Bounes V, Mas A, Payen D, Petrie D , Roessler MS et al (2014) Prehospital Noninvasive Ventilation for Acute Respiratory Failure: Systematic Review, Network Meta-analysis, and Individual Patient Data Meta-analysis. Academic Emergency Medicine, 21(9), 960-970. View this article in WRRO
• Poku E, Rathbone J, Everson-Hock E, Essat M, Wong R, Pandor A & Wailoo A (2014) The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review. BMJ Open, 4. View this article in WRRO
• Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014) Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.. Diabet Med, 31(4), 477-486.
• Kaltenthaler E, Pandor A & Wong R (2014) The effectiveness of sexual health interventions for people with severe mental illness: a systematic review.. Health Technol Assess, 18(1), 1-74. View this article in WRRO
• Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P & Wyld L (2013) Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.. Health Technol Assess, 17(44), 1-302. View this article in WRRO
• Holmes MW, Goodacre S, Stevenson MD, Pandor A & Pickering A (2013) The cost-effectiveness of diagnostic management strategies for children with minor head injury.. Arch Dis Child, 98(12), 939-944.
• Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013) Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.. Health Technol Assess, 17(32), 1-vi. View this article in WRRO
• Pandor A, Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, Cleland JGF, Cowie MR & Wong R (2013) Remote monitoring after recent hospital discharge in patients with heart failure: A systematic review and network meta-analysis. Heart, 99(23), 1717-1726.
• Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J , Cowie MR et al (2013) Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.. BMJ Open, 3(9), e003250. View this article in WRRO
• Pandor A (2013) Home telemonitoring or structured telephone support programmes for patients with heart failure. Health Technology Assessment, 17(32).
• Whyte S, Pandor A & Stevenson M (2012) Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal.. Pharmacoeconomics, 30(12), 1119-1132.
• Stevenson M & Pandor A (2012) Febuxostat for the treatment of hyperuricemia in patients with gout: The National Institute for Health and Clinical Excellence single technology appraisal process. PharmacoEconomics - Italian Research Articles, 14(1), 47-54.
• Holmes MW, Goodacre S, Stevenson MD, Pandor A & Pickering A (2012) The cost-effectiveness of diagnostic management strategies for adults with minor head injury.. Injury, 43(9), 1423-1431.
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A (2012) Diagnostic accuracy of clinical characteristics for identifying CT abnormality after minor brain injury: a systematic review and meta-analysis.. J Neurotrauma, 29(5), 707-718.
• Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS & Stevenson M (2012) Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?. Eur J Prev Cardiol, 19(3), 474-483.
• Holmes MW, Goodacre S, Stevenson MD, Pandor A & Pickering A (2011) The cost-effectiveness of diagnostic management strategies for adults with minor head injury. Injury.
• Pickering A, Goodacre S, Pandor A, Harnan S, Holmes M & Fitzgerald P (2011) Diagnosis and management of minor head injury in the UK. Journal of Paramedic Practice, 3(8), 418-423.
• Pandor A, Goodacre S, Harnan S, Holmes M, Pickering A, Fitzgerald P, Rees A & Stevenson M (2011) Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.. Health Technol Assess, 15(27), 1-202.
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) Clinical decision rules for adults with minor head injury: a systematic review.. J Trauma, 71(1), 245-251.
• Pickering A, Harnan S, Fitzgerald P, Pandor A & Goodacre S (2011) Clinical decision rules for children with minor head injury: A systematic review. Archives of Disease in Childhood, 96(5), 414-421.
• Stevenson M & Pandor A (2011) Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.. Pharmacoeconomics, 29(2), 133-140.
• Whyte S, Pandor A, Stevenson M & Rees A (2010) Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.. Health technology assessment (Winchester, England), 14(Suppl. 2), 47-53. View this article in WRRO
• Goodacre SW, Pandor A & Pickering A (2010) Management of isolated minor head injury in the UK.. Emerg Med J, 27(11), 856-859.
• Stevenson M & Pandor A (2009) Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. HEALTH TECHNOL ASSES, 13, 37-42.
• Pandor A, Fitzgerald P, Stevenson M & Papaioannou D (2009) Mifamurtide for the treatment of osteosarcoma: a single technology appraisal. HEALTH TECHNOL ASSES, 13, 55-60.
• Ara R, Rafia R, Ward SE, Wierzbicki AS, Reynolds TM, Rees A & Pandor A (2009) Are intensive lipid-lowering regimens an optimal economic strategy in patients with ACS? An acute and chronic perspective.. Expert Rev Pharmacoecon Outcomes Res, 9(5), 423-433.
• Pandor A, Ara RM, Tumur I, Wilkinson AJ, Paisley S, Duenas A, Durrington PN & Chilcott J (2009) Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials.. J Intern Med, 265(5), 568-580.
• Ara R, Pandor A, Stevens J, Rees A & Rafia R (2009) Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation.. Health technology assessment (Winchester, England), 13(34).
• Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Wilkinson A, Durrington P & Chilcott J (2008) Estimating the health benefits and costs associated with ezetimibe coadministered with statin therapy compared with higher dose statin monotherapy in patients with established cardiovascular disease: results of a Markov model for UK costs using data registries.. Clin Ther, 30(8), 1508-1523.
• Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S & Chilcott J (2008) Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.. Health Technol Assess, 12(21), iii-212.
• Ara R, Pandor A, Tumur I, Paisley S, Duenas A, Williams R, Rees A, Wilkinson A, Durrington P & Chilcott J (2008) Cost effectiveness of ezetimibe in patients with cardiovascular disease and statin intolerance or contraindications: a Markov model.. Am J Cardiovasc Drugs, 8(6), 419-427.
• Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W & Payne N (2007) A systematic review and economic evaluation of statins for the prevention of coronary events.. Health Technol Assess, 11(14), 1-iv.
• Eggington S, Tappenden P, Pandor A, Paisley S, Saunders M, Seymour M, Sutcliffe P & Chilcott J (2006) Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer.. Br J Cancer, 95(9), 1195-1201. View this article in WRRO
• Pandor A, Eggington S, Paisley S, Tappenden P & Sutcliffe P (2006) The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.. Health technology assessment (Winchester, England), 10(41).
• Pandor A, Eggington S, Paisley S, Tappenden P & Sutcliffe P (2006) The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. HEALTH TECHNOL ASSES, 10(41), 1-+. View this article in WRRO
• Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D & Akehurst R (2006) A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK.. Int J Cardiol, 109(3), 307-316.
• Pandor A, Eastham J, Chilcott J, Paisley S & Beverley C (2006) Economics of tandem mass spectrometry screening of neonatal inherited disorders.. Int J Technol Assess Health Care, 22(3), 321-326. View this article in WRRO
• Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C & Akehurst R (2005) Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK.. Curr Med Res Opin, 21(1), 101-112.
• Pandor A, Eastham J, Beverley C, Chilcott J & Paisley S (2004) Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. HEALTH TECHNOL ASSES, 8(12), 1-+.
• Hautvast JL, Pandor A, Burema J, Tolboom JJ, Chishimba N, Monnens LA & van Staveren WA (2000) Nutritional status of breastfed infants in rural Zambia: comparison of the National Center for Health Statistics growth reference versus the WHO 12-month breastfed pooled data set.. Bull World Health Organ, 78(4), 535-541.
• Davis S, Pandor A, Sampson F, Hamilton J, Nelson-Piercy C, Beverley H, Jahnavi D, Goodacre S, Carser R, Rooney G & Clowes M () Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research. Health Technology Assessment.
• Pandor A, Daru J, Hunt B, Rooney G, Hamilton J, Clowes M, Goodacre S, Nelson-Piercy C & Davis S () Risk assessment models for venous thromboembolism in pregnancy and in the puerperium: a systematic review. BMJ Open.
• Whyte S, Pandor A, Stevenson M & Rees A () Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer. Health Technology Assessment, 14(Suppl 2), 47-53.
• Stevenson M & Pandor A () Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal. Health Technology Assessment, 13(Suppl 3), 37-42.
• Pandor A, Thokala P, Goodacre S, Poku E, Stevens JW, Ren S, Cantrell A, Perkins GD, Ward M & Penn-Ashman J () Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation. Health Technology Assessment, 19(42), 1-102. View this article in WRRO

Conference proceedings papers

• Davis S, Pandor A, Sampson F, Nelson-Piercy C, Hunt B & Daru J (2023) Thromboprophylaxis during pregnancy and the puerperium: A systematic review, qualitative study and economic evaluation to estimate the value and acceptability of future research. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 130 (pp 20-20)
• Pandor A, Gomersall T, Stevens JW & Wong R (2015) Remote monitoring strategies for patients with stable Heart failure: a systematic review and Network meta-analysis. Value in Health, Vol. 18(3) (pp A248-A248)
• Bessey A, Chilcott J, Pandor A & Paisley S (2014) The Cost-Effectiveness of Expanding the Nhs Newborn Bloodspot Screening Programme To Include Homocystinuria (Hcu), Maple Syrup Urine Disease (Msud), Glutaric Aciduria Type 1 (Ga1), Isovaleric Acidaemia (Iva), and Long-Chain Hydroxyacyl-Coa Dehydrogenase Deficiency (Lchadd). Value in Health, Vol. 17(7) (pp A531-A531)
• Brennan A, Thokala P, Baalbaki H, Stevens JW, Wang J & Pandor A (2012) TELEMONITORING AFTER DISCHARGE WITH HEART FAILURE - COST-EFFECTIVENESS MODELLING OF ALTERNATIVE SERVICE DESIGNS. VALUE IN HEALTH, Vol. 15(7) (pp A360-A360)
• Pandor A, Harnan SE, Goodacre SW, Pickering A, Fitzgerald P & Rees AC (2011) DIAGNOSTIC ACCURACY OF CLINICAL CHARACTERISTICS FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A245-A245)
• Pickering A, Fitzgerald P, Harnan SE, Pandor A & Goodacre SW (2011) BIOCHEMICAL MARKERS FOR THE IDENTIFICATION OF INTRACRANIAL INJURY FOLLOWING MINOR HEAD INJURY: A SYSTEMATIC REVIEW AND META-ANALYSIS. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• Harnan SE, Pickering A, Pandor A & Goodacre SW (2011) CLINICAL DECISION RULES FOR ADULTS WITH MINOR HEAD INJURY: A SYSTEMATIC REVIEW. VALUE IN HEALTH, Vol. 14(7) (pp A244-A244)
• Allder SJ, Stevenson M, Doyle C, Pandor A, Rothwell P, Venables G & Thomas SM (2004) Should we treat TIA as a medical emergency?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, Vol. 75(8) (pp 1217-1217)
• Thokala P, Hassan B, Abdullah P, Stevens JW & Alan B () Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure. International Journal of Integrated Care, Vol. 13(7)

Reports

• Leaviss J, Harnan S, Pandor A & Cantrell A (2022) Newborn screening for congenital adrenal hyperplasia. External review against programme appraisal criteria for the UK National Screening Committee

Website content

• Pandor A, Kaltenthaler E, Cooper K, James MM-S & Wong R SelecTing Approaches for Rapid Reviews (STARR) Decision Tool.

Posters

• Archer R, Clowes M, Hamilton J, Pandor A, Stevenson MD, Stevens JW, Hock ES & Essat M (2018) Addressing challenges in the conduct of a systematic review of clinical prediction models in rheumatoid arthritis. 25th Cochrane Colloquium, Edingurgh.
• Hamilton J, Archer R, Stevens J, Stevenson M, Hock E, Clowes M, Essat M, Poku E & Pandor A (2018) Clinical prediction models for patients with early rheumatoid arthritis: A systematic review and evidence synthesis. MEMTAM (Methods for Evaluation of medical prediction Models, Test And Biomarkers), Utecht, The Nethe.
• Goodacre S (2014) PRE-HOSPITAL NON-INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE: A SYSTEMATIC REVIEW AND NETWORK META ANALYSIS.
• Poku E, Rathbone J, Hock E, Essat M, Wong R, Pandor A & Wailoo A (2013) Safety of intravitreal bevacizumab as a monotherapy in ophthalmic conditions: systematic review. Health Technology Assessment International.
• Pickering A, Harnan S, Pandor A, Fitzgerald P & Goodacre S (2010) Clinical Decision Rules for children with minor head injury: A systematic review. European Society of Emergency Medicine,(EuSEM) Stockholm.
• Pickering A, Harnan S, Pandor A & Goodacre S A systematic review of Clinical Decision Rules in the management of adult minor head injury.
• Brennan A, Thokala P, Baalbaki H, Stevens J, Wang J & Pandor A Telemonitoring after discharge with heart failure - costeffectiveness modelling of alternative service designs (2012).
• Bessey A, Chilcott J, Paisley S & Pandor A The cost-effectiveness of expanding the NHS newborn bloodspot screening programme to include homocystinuria (HCU), maple syrup urine disease (MSUD), glutaric aciduria type 1 (GA1), isovaleric acidaemia (IVA), and long-chain hydroxyl acyl-CoA dehydrogenase deficiency (LCHADD) (2014).
• Pandor A, Harnan S, Goodacre S, Pickering A, Fitzgerald P & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
• Pickering A, Harnan S, Pandor A & Goodacre S Clinical Decision Rules for children with minor head injury: A systematic review.
• Pandor A, Harnan S, Goodacre S, Pickering A & Rees A Diagnostic accuracy of clinical characteristics following minor head injury: a systematic review and meta-analysis.
• Pandor A, Wong R, Stevens JW & Gomersall T Remote monitoring strategies for patients with stable heart failure: A systematic review and network meta-analysis (ISPOR 20th Annual International Meeting 16-20 May 2015).
• Pickering A, Fitzgerald P, Harnan S, Pandor A & Goodacre S The role of biochemical markers in the identification of intracranial pathology following minor head injury: a systematic review and meta-analysis.
• Harnan S, Pickering A, Pandor A & Goodacre S Clinical decision rules for adults with minor head injury: a systematic review.
• Goodacre S, Pandor A, Poku E, Stevens JW, Ren S & Cantrell A Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and network meta-analysis. 999 EMS Research Forum Conference.

Other

• Pandor A, Eastham J, Beverley C, Chilcott J & Paisley S (2005) Clinical-effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. INT J TECHNOL ASSESS, 21(1), 150-150. View this article in WRRO

Preprints

• Sampson FC, Davis S, Kuczawski M, Carser R, Hunt BJ, Goodacre S, Pandor A, Nelson-Piercy C & Daru J (2024) What influences women’s decisions to participate in trials for prevention of venous thromboembolism during pregnancy and the puerperium: a qualitative study, Research Square Platform LLC.
• Robinson A, Thorne W, Wu BP, Pandor A, Essat M, Stevenson M & Song X (2023) Bio-SIEVE: Exploring Instruction Tuning Large Language Models for Systematic Review Automation, arXiv.